The MYCN/Aurora-A complex is a cyclin activating kinase for CDK12
Mueller, M.; Eing, L.; Uhl, L.; Schmitz, M.; Kaneva, I.; Byrne, D. P.; Fleischhauer, D.; Burgess, S. G.; Fischer, S.; Gebauer, N.; Nancy-Portebois, V.; Kaltheuner, I. H.; Ha, S. A.; Schuelein-Voelk, C.; Solvie, D.; Richards, M. W.; Vidal, R.; Brand, M.; Papadopoulos, D.; Bayliss, R. W.; Eyers, P. A.; Eyers, C. E.; Geyer, M.; Eilers, M.; Buechel, G.
Show abstract
Deregulated MYCN is a driver of aggressive pediatric and adult neuroendocrine tumors, but critical oncogenic processes downstream of MYCN remain poorly defined. In neuroblastoma, MYCN interacts with and activates the Aurora-A kinase. Here we show that Aurora-A is a CDK-activating kinase for CDK12 by phosphorylating T893 in the T-loop, thereby enhancing its kinase activity. Aurora-A-dependent activation of CDK12 controls phosphorylation of T4 of RNA polymerase and recruits transcription termination complexes, thereby preventing transcription-replication conflicts. Enhanced crosslinking and immunoprecipitation sequencing reveals that Aurora-A associates with splice sites on nascent RNA. RNA-bound Aurora-A is catalytically inactive. MYCN competes with RNA for binding to Aurora-A and displaces Aurora-A from RNA in cells, promoting its CDK12 kinase activity. Combining Aurora-A and CDK12 inhibition potently suppresses the growth of MYCN-amplified neuroblastoma cells and patient-derived xenografts. Our data demonstrate that an Aurora-A/CDK12-dependent transcription termination pathway is a critical and targetable dependency of MYCN-driven tumors.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 96%
- 53BP1 deficiency leads to hyperrecombination using break-induced replication (BIR) 96%
- The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress 96%
Similar papers in this journal
- Identification of Novel Modulators of the ALT Pathway Through a Native FISH-Based Optical Screen 97%
- The MYCN 5' UTR as a therapeutic target in neuroblastoma 97%
- Activity-assembled nBAF complex mediates rapid immediate early gene transcription by regulating RNA Polymerase II productive elongation. 96%
Similar papers in this journal
- Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger Cyclin K degradation 95%
- Human promoter directionality is determined by transcriptional initiation and the opposing activities of INTS11 and CDK9 95%
- Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.